U.S. markets closed
  • S&P 500

    4,411.79
    +44.31 (+1.01%)
     
  • Dow 30

    35,061.55
    +238.20 (+0.68%)
     
  • Nasdaq

    14,836.99
    +152.39 (+1.04%)
     
  • Russell 2000

    2,209.65
    +10.17 (+0.46%)
     
  • Crude Oil

    72.17
    +0.26 (+0.36%)
     
  • Gold

    1,802.10
    -3.30 (-0.18%)
     
  • Silver

    25.24
    -0.14 (-0.56%)
     
  • EUR/USD

    1.1770
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.2860
    +0.0210 (+1.66%)
     
  • GBP/USD

    1.3754
    -0.0013 (-0.10%)
     
  • USD/JPY

    110.5100
    +0.3950 (+0.36%)
     
  • BTC-USD

    34,472.57
    +565.59 (+1.67%)
     
  • CMC Crypto 200

    786.33
    -7.40 (-0.93%)
     
  • FTSE 100

    7,027.58
    +59.28 (+0.85%)
     
  • Nikkei 225

    27,548.00
    +159.80 (+0.58%)
     

OPKO Health Offloads Fill and Finish Manufacturing Facility in Ireland To Horizon Therapeutics

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • OPKO Health Inc's (NASDAQ: OPK) subsidiary, EirGen Pharma Ltd, has agreed to sell one of its facilities in Waterford, Ireland, to Horizon Therapeutics plc (NASDAQ: HZNP) for $65 million.

  • The facility houses EirGen's sterile-fill-finish business. EirGen's R&D employees who were located at the site will transition to a new facility.

  • "This facility in Ireland is no longer a core component of our ongoing operations and business strategy, and its sale allows us to focus EirGen's business on oral solid dose products," said Phillip Frost, Chairman and CEO of OPKO.

  • OPKO expects the transaction to close in approximately one month.

  • Price Action: OPK shares are down 1.06% at $3.73 during the premarket session on the last check Thursday, while HZNP shares closed at $90.9 on Wednesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.